cinacalcet has been researched along with Disease Models, Animal in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Eastell, R; Esfahani, SHZ; Newell-Price, J; Ramezanipour, N; Ross, RJ; Trevitt, G; Wilkinson, IR | 1 |
| Bayliss, AL; Codner, G; Gorvin, CM; Hannan, FM; Kooblall, KG; Stevenson, M; Stewart, M; Stokes, VJ; Teboul, L; Thakker, RV; Wells, S | 1 |
| Cancela, ML; Carvalho, FR; Fernandes, AR; Gavaia, PJ | 1 |
| Brown, SD; Cox, RD; Gorvin, CM; Hannan, FM; Hough, TA; Howles, SA; Nesbit, MA; Paudyal, A; Piret, SE; Stewart, M; Thakker, RV; Wells, S | 1 |
| Eräranta, A; Lakkisto, P; Mustonen, J; Niemelä, O; Paavonen, T; Pörsti, I; Tikkanen, I; Törmänen, S | 1 |
| Akizawa, T; Fukagawa, M; Haruyama, W; Hisada, Y; Kawata, T; Masuda, N; Miyazaki, H; Murai, M; Shoukei, Y; Tokunaga, S; Wada, M; Yanagida, T | 1 |
| Aleksinskaya, MA; de Bruin, RG; Fibbe, WE; Koekkoek, KM; Massy, ZA; Monge, M; Rabelink, TJ; Siebelt, M; Slot, EM; van Pel, M; van Zonneveld, AJ; Weinans, H | 1 |
| Alexander, RT; Beggs, MR; Chen, XZ; Dimke, H; Flockerzi, V; Lee, JJ; Liu, X; O'Neill, D; Weissgerber, P | 1 |
| Alexander, ST; Baruch, A; Dong, J; Janes, J; Johnson, RM; Karim, F; Maclean, D; Mendel, DB; Sho, E; Walter, S; Yin, Q | 1 |
| Enoki, Y; Fukagawa, M; Ikegami, K; Imafuku, T; Ishima, Y; Komaba, H; Maruyama, T; Matsushita, K; Miyamura, S; Murata, M; Nishida, K; Otagiri, M; Sakaguchi, Y; Sugimoto, R; Tanaka, M; Watanabe, H | 1 |
| Kawata, T; Kobayashi, N; Koyama, C; Miyata, S; Nagano, N; Obi, M; Wada, M; Wakita, S | 1 |
| Yokoyama, K | 1 |
| Finch, JL; Lane, N; Nakamura, H; Shahnazari, M; Slatopolsky, E; Tokumoto, M; Yao, W | 1 |
| Hatamura, I; Kusano, E; Mato, M; Nakazawa, E; Ogura, M; Onishi, A; Saji, F; Shiizaki, K; Watanabe, Y | 1 |
| Colloton, M; Davis, J; Henley, CM; Martin, D; Miller, G; Shatzen, E | 1 |
| Cattley, RC; Colloton, M; Henley, C; Lacey, D; Martin, D; Shatzen, E; Towler, DA | 1 |
17 other study(ies) available for cinacalcet and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Development of a Hypoparathyroid Male Rodent Model for Testing Delayed-Clearance PTH Molecules.
Topics: Animals; Calcium; CHO Cells; Cinacalcet; Cricetulus; Disease Models, Animal; Hypoparathyroidism; Male; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphates; Rats; Rats, Wistar; Treatment Outcome | 2022 |
Ap2s1 mutation causes hypercalcaemia in mice and impairs interaction between calcium-sensing receptor and adaptor protein-2.
Topics: Adaptor Protein Complex 2; Adaptor Protein Complex sigma Subunits; Animals; Bone Density; Calcium; Cinacalcet; CRISPR-Cas Systems; Disease Models, Animal; Fibroblast Growth Factor-23; Gene Editing; Humans; Hypercalcemia; Mice; Mutation; Phenotype; Receptors, Calcium-Sensing | 2021 |
Improved regeneration and de novo bone formation in a diabetic zebrafish model treated with paricalcitol and cinacalcet.
Topics: Amputation, Surgical; Animal Fins; Animals; Calcimimetic Agents; Cell Differentiation; Cinacalcet; Diabetes Mellitus, Experimental; Disease Models, Animal; Ergocalciferols; Immunohistochemistry; Osteoblasts; Osteogenesis; Real-Time Polymerase Chain Reaction; Regeneration; Zebrafish | 2017 |
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation.
Topics: Administration, Oral; Animals; Calcium; Cinacalcet; Disease Models, Animal; Ethylnitrosourea; Female; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Hypercalcemia; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Molecular; Mutation; Parathyroid Hormone; Receptors, Calcium-Sensing; Sequence Alignment; Sequence Analysis, DNA; Serum Albumin; Signal Transduction | 2017 |
Endothelin A receptor blocker and calcimimetic in the adenine rat model of chronic renal insufficiency.
Topics: Adenine; Animals; Calcimimetic Agents; Cinacalcet; Disease Models, Animal; Endothelin A Receptor Antagonists; Isoxazoles; Male; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Thiophenes | 2017 |
A novel calcimimetic agent, evocalcet (MT-4580/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro.
Topics: Administration, Oral; Animals; Calcimimetic Agents; Callithrix; Cinacalcet; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gastrointestinal Tract; HEK293 Cells; Humans; Isoenzymes; Male; Molecular Structure; Parathyroid Glands; Parathyroid Hormone; Rats, Wistar; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Vomiting | 2018 |
Chronic kidney failure mineral bone disorder leads to a permanent loss of hematopoietic stem cells through dysfunction of the stem cell niche.
Topics: Animals; Bone Density; Bone Marrow Diseases; Cell Count; Cell Cycle; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Disease Models, Animal; Endothelium, Vascular; Female; Hematopoietic Stem Cells; Homeostasis; Lymphopoiesis; Macrophages; Mice; Mice, Inbred C57BL; Nephrectomy; Osteoblasts; Stem Cell Niche | 2018 |
Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption.
Topics: Animals; Calcimimetic Agents; Calcium; Calcium Channels; Cinacalcet; Disease Models, Animal; Estrenes; Female; Gene Knock-In Techniques; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Intestinal Absorption; Intestinal Mucosa; Kidney Tubules; Male; Mice; Mice, Transgenic; Oocytes; Parathyroid Hormone; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Pyrrolidinones; Receptors, Calcium-Sensing; TRPV Cation Channels; Type C Phospholipases; Xenopus | 2019 |
Comparison of AMG 416 and cinacalcet in rodent models of uremia.
Topics: Animals; Calcimimetic Agents; Cinacalcet; Disease Models, Animal; Humans; Male; Naphthalenes; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Recovery of Function; Treatment Outcome; Uremia | 2014 |
Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Caco-2 Cells; Calcimimetic Agents; Cinacalcet; Disease Models, Animal; Down-Regulation; Humans; Hyperparathyroidism, Secondary; Hyperuricemia; Intestinal Elimination; Intestinal Mucosa; Intestines; Kidney; Male; Neoplasm Proteins; Parathyroid Hormone; Rats, Sprague-Dawley; Renal Elimination; Time Factors; Uremia; Uric Acid | 2017 |
Cinacalcet suppresses calcification of the aorta and heart in uremic rats.
Topics: Animals; Aorta; Calcinosis; Cinacalcet; Disease Models, Animal; Hyperparathyroidism, Secondary; Myocardium; Naphthalenes; Parathyroid Hormone; Rats; Uremia | 2008 |
Clinical issues regarding cinacalcet hydrochloride in Japan.
Topics: Animals; Cinacalcet; Disease Models, Animal; Drug Costs; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Japan; Naphthalenes; Osteitis; Parathyroid Glands; Parathyroid Hormone; Randomized Controlled Trials as Topic; Receptors, Calcitriol; Vitamin D; Vitamins | 2009 |
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
Topics: Animals; Biomarkers; Bone Resorption; Calcitriol; Calcium; Cinacalcet; Creatinine; Disease Models, Animal; Ergocalciferols; Female; Fibroblast Growth Factors; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Uremia | 2010 |
Development and prevention of morphologic and ultrastructural changes in uremia-induced hyperplastic parathyroid gland.
Topics: Animals; Calcitriol; Capillaries; Cinacalcet; Disease Models, Animal; Hyperparathyroidism, Secondary; Hyperplasia; Male; Naphthalenes; Nephrectomy; Organelles; Parathyroid Glands; Phosphorus; Phosphorus, Dietary; Rats; Rats, Sprague-Dawley; Uremia | 2011 |
Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.
Topics: Animals; Calcium; Cell Proliferation; Cinacalcet; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Uremia | 2012 |
1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism.
Topics: Animals; Aortic Diseases; Calcinosis; Calcitriol; Calcium; Calcium Channel Agonists; Chronic Disease; Cinacalcet; Disease Models, Animal; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley | 2005 |